Provexis plc NZCA.F Stock
Provexis plc Price Chart
Provexis plc NZCA.F Financial and Trading Overview
| Provexis plc stock price | 0.0055 EUR |
| Previous Close | 0.005 EUR |
| Open | 0.005 EUR |
| Bid | 0.0045 EUR x 100 |
| Ask | 0.02 EUR x 100 |
| Day's Range | 0.005 - 0.005 EUR |
| 52 Week Range | 0.005 - 0.0095 EUR |
| Volume | 10K EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 15.55M EUR |
| Beta (5Y Monthly) | 1.31839 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NZCA.F Valuation Measures
| Enterprise Value | 9.81M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 39.42872 |
| Price/Book (mrq) | 4.9999995 |
| Enterprise Value/Revenue | 24.884 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Provexis plc Stock Price History
| Beta (5Y Monthly) | 1.31839 |
| 52-Week Change | -37.50% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0095 EUR |
| 52 Week Low | 0.005 EUR |
| 50-Day Moving Average | 0.006 EUR |
| 200-Day Moving Average | 0.0066475 EUR |
NZCA.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 2.22B |
| Float | 1.81B |
| Short Ratio | N/A |
| % Held by Insiders | 21.05% |
| % Held by Institutions | 6.79% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2022 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | March 31, 2023 |
Profitability
| Profit Margin | -63.35% |
| Operating Margin (ttm) | -83.17% |
| Gross Margin | 87.68% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -18.56% |
| Return on Equity (ttm) | -26.89% |
Income Statement
| Revenue (ttm) | 394.34K EUR |
| Revenue Per Share (ttm) | 0 EUR |
| Quarterly Revenue Growth (yoy) | -15.099% |
| Gross Profit (ttm) | 380.05K EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -249845 EUR |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 744.55K EUR |
| Total Cash Per Share (mrq) | 0 EUR |
| Total Debt (mrq) | 0 EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 6.617 |
| Book Value Per Share (mrq) | 0.001 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -272474 EUR |
| Levered Free Cash Flow (ttm) | -223873 EUR |
Profile of Provexis plc
| Country | Germany |
| State | N/A |
| City | Reading |
| Address | 2 Blagrave Street |
| ZIP | RG1 1AZ |
| Phone | 44 7490 391 888 |
| Website | https://www.provexis.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
Provexis plc, together with its subsidiaries, develops, licenses, markets, and sells functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in various foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and heart function. The company sells its products through distributors and online channels. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.
Q&A For Provexis plc Stock
What is a current NZCA.F stock price?
Provexis plc NZCA.F stock price today per share is 0.0055 EUR.
How to purchase Provexis plc stock?
You can buy NZCA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Provexis plc?
The stock symbol or ticker of Provexis plc is NZCA.F.
Which industry does the Provexis plc company belong to?
The Provexis plc industry is Drug Manufacturers-Specialty & Generic.
How many shares does Provexis plc have in circulation?
The max supply of Provexis plc shares is 3.13B.
What is Provexis plc Price to Earnings Ratio (PE Ratio)?
Provexis plc PE Ratio is now.
What was Provexis plc earnings per share over the trailing 12 months (TTM)?
Provexis plc EPS is 0 EUR over the trailing 12 months.
Which sector does the Provexis plc company belong to?
The Provexis plc sector is Healthcare.